Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dölken

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Advances in Cancer Research|July 13, 2001
Detection of minimal residual diseaseG Dölken
Bone Marrow Transplantation|March 21, 2000
Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantationC Hirt, G Dölken
Journal of the National Cancer Institute|May 1, 1977
A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatantsG Dölken, G Klein
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1980
Isolation of autologous antibodies to antigens-associated with Hodgkin's diseaseG Dölken, G W Löhr
Deutsche Medizinische Wochenschrift (1946)|July 1, 2004
[Malignant melanoma of the anorectal mucosa]C Sucker, G Dölken, M Stockschläder
Histochemistry|January 1, 1975
Immunofluorescent localization of glycogenolytic and glycolytic enzyme proteins and of malate dehydrogenase isozymes in cross-striated skeletal muscle and heart of the rabbitG Dölken, E Leisner, D Pette
Biotechniques|December 24, 1998
Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probesL Dölken, F Schüler, G Dölken
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Serum antibodies to a normal cellular protein (P-65) in patients with Hodgkin's diseaseF W Hirsch, J Scholl, G Dölken
Klinische Wochenschrift|October 15, 1979
Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg)H E Blum, G Dölken, W Gerok
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseasesG Dölken, G Illerhaus, C Hirt, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Advances in Cancer Research|July 13, 2001
Detection of minimal residual diseaseG Dölken
Bone Marrow Transplantation|March 21, 2000
Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantationC Hirt, G Dölken
Journal of the National Cancer Institute|May 1, 1977
A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatantsG Dölken, G Klein
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1980
Isolation of autologous antibodies to antigens-associated with Hodgkin's diseaseG Dölken, G W Löhr
Deutsche Medizinische Wochenschrift (1946)|July 1, 2004
[Malignant melanoma of the anorectal mucosa]C Sucker, G Dölken, M Stockschläder
Histochemistry|January 1, 1975
Immunofluorescent localization of glycogenolytic and glycolytic enzyme proteins and of malate dehydrogenase isozymes in cross-striated skeletal muscle and heart of the rabbitG Dölken, E Leisner, D Pette
Biotechniques|December 24, 1998
Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probesL Dölken, F Schüler, G Dölken
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Serum antibodies to a normal cellular protein (P-65) in patients with Hodgkin's diseaseF W Hirsch, J Scholl, G Dölken
Klinische Wochenschrift|October 15, 1979
Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg)H E Blum, G Dölken, W Gerok
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseasesG Dölken, G Illerhaus, C Hirt, et al.
Pageof 6